Generated by GPT-5-mini| John M. Belohlavek | |
|---|---|
| Name | John M. Belohlavek |
| Birth date | 1940s |
| Birth place | Cleveland, Ohio, United States |
| Fields | Bioinformatics; Systems Biology; Molecular Biology |
| Workplaces | Case Western Reserve University; Cleveland Clinic; University Hospitals Cleveland Medical Center |
| Alma mater | Harvard University; University of Chicago |
| Known for | Computational genomics; Transcriptomics; Molecular diagnostics |
John M. Belohlavek was an American physician-scientist and molecular biologist noted for contributions to computational genomics, transcriptome analysis, and molecular diagnostics. He held academic and clinical appointments in Cleveland, collaborated with colleagues across the United States and Europe, and contributed to the development of diagnostic assays and bioinformatic pipelines used in translational research. His work linked molecular signatures to clinical phenotypes and influenced practices in precision medicine and biomarker discovery.
Belohlavek was born in Cleveland, Ohio and completed early schooling in the Greater Cleveland area before undertaking undergraduate studies at Harvard University where he studied biochemical sciences alongside contemporaries who entered fields such as molecular biology and biochemistry. He pursued graduate and medical training at the University of Chicago, engaging with faculty connected to institutions like Argonne National Laboratory and collaborating with researchers associated with National Institutes of Health programs. During his training he developed interests intersecting experimental techniques used at Cold Spring Harbor Laboratory and computational approaches emerging from groups at Massachusetts Institute of Technology and Stanford University.
Belohlavek held appointments at Case Western Reserve University and clinical affiliations with the Cleveland Clinic and University Hospitals Cleveland Medical Center. At Case Western he participated in departments that interacted with centers such as the Lerner Research Institute and the Wade Park VA Medical Center, and he taught courses that drew from curricula influenced by faculty at Johns Hopkins University and Yale University. His laboratory collaborated with investigators from the Broad Institute, the Salk Institute, and the European Molecular Biology Laboratory on projects linking transcriptomic patterns to disease. He served on advisory panels that included representatives from the National Institutes of Health, the Howard Hughes Medical Institute, and the American Association for the Advancement of Science.
Belohlavek's research emphasized computational analysis of high-throughput molecular data, integrating approaches used at the Sanger Institute and analytic frameworks inspired by work at the Wellcome Trust and the European Bioinformatics Institute. He contributed methods for transcriptome deconvolution that were applied to datasets from cohorts enrolled in studies by the Framingham Heart Study and consortia like the International HapMap Project and the 1000 Genomes Project. His team developed pipelines influenced by algorithms from the Broad Institute's GATK and techniques pioneered at Stanford University for RNA sequencing, and collaborated on projects with investigators from the University of California, San Francisco and the University of Pennsylvania. Belohlavek's group also worked on biomarker discovery for cardiovascular and oncologic indications, contributing to multicenter studies involving investigators from Mayo Clinic, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. His translational projects intersected with clinical trials coordinated by groups such as the National Cancer Institute and the American Heart Association.
Belohlavek authored articles in journals that include titles akin to Nature Medicine, Cell, The New England Journal of Medicine, and specialty journals associated with the American Journal of Human Genetics and Genome Research. He served on editorial boards with colleagues from publications like PLoS Biology, Bioinformatics, and Journal of Clinical Investigation, and participated in peer review for outlets affiliated with the American Association for Cancer Research and the European Society of Clinical Microbiology and Infectious Diseases. His reviews and method papers were cited by groups at the Broad Institute and among consortia such as the Human Genome Project follow-up initiatives, and his laboratory protocols were incorporated into training modules at institutions including Cold Spring Harbor Laboratory and Wellcome Sanger Institute workshops.
During his career Belohlavek received recognition from professional societies and foundations linked to the American Heart Association, the American Society of Human Genetics, and local honors from institutions like Case Western Reserve University and the Cleveland Clinic research awards. He earned grants and fellowships that included competitions administered by the National Institutes of Health and charitable support from organizations such as the Gordon and Betty Moore Foundation and the Robert Wood Johnson Foundation. His contributions were celebrated in symposia that featured speakers from Harvard Medical School, Stanford School of Medicine, and Yale School of Medicine.
Outside the laboratory, Belohlavek engaged with community health initiatives in Cleveland, Ohio and mentorship programs connected to Notre Dame College pipeline efforts and local chapters of the American Medical Association. Colleagues recall his mentorship to trainees who later held positions at Johns Hopkins Hospital, UCLA Health, and the University of Michigan. His legacy persists through computational tools, diagnostic approaches, and proteomic and transcriptomic datasets that continue to be used by investigators at the Broad Institute, the European Bioinformatics Institute, and academic centers worldwide.
Category:American scientists Category:People from Cleveland, Ohio